Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Background: Papillary thyroid cancer (PTC) is the most common subtype of thyroid cancer,
and inflammation relates significantly to its initiation and prognosis. Systematic exploration …

Background: This study aims to compare the seventh and eighth editions of the American
Joint Commission on Cancer/Union for International Cancer Control (AJCC/UICC) tumor …

In the past three decades, the thyroid cancer incidence has surged globally. Herein, the
Taiwan National Health Insurance database was used to identify thyroid cancer patients and …

Differentiated thyroid cancer (DTC) is the most common endocrine malignancy with a
growing incidence worldwide. The initial conventional management is surgery, followed by …

Background and Objectives. The clinicopathological risk factors to predict recurrence of
papillary thyroid cancer (PTC) patients remain controversial. Methods. PTC patients treated …

Thyroid cancer, a common endocrine malignancy, is one of the leading death causes
among endocrine tumors. The diagnosis of pathological section analysis suffers from …

Though many patients with thyroid cancer may be indolent, there are still about 50% lymph
node metastases and 20% the recurrence rates. There is still no ideal method to predict its …

Although the majority of papillary thyroid cancers (PTC) are indolent, a subset of PTCs
behaves aggressively due to extensive invasion and distant metastasis. Integrin β4, a …

Abstract Papillary Thyroid Carcinoma (PTC) accounts for approximately 85% of patients with
thyroid cancer. Despite its indolent nature, progression to higher stages is expected in a …